Do KA - Search Results

1

A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer.

León-Letelier RA, Chen Y, Ballaro R, Irajizad E, Do KA, Maitra A, Zhang J, Schmidt CM, Fahrmann JF. León-Letelier RA, et al. Among authors: do ka. J Cancer Immunol (Wilmington). 2024;6(4):148-153. doi: 10.33696/cancerimmunol.6.095. J Cancer Immunol (Wilmington). 2024. PMID: 39713022 No abstract available.

2

Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer.

León-Letelier RA, Dou R, Vykoukal J, Yip-Schneider MT, Maitra A, Irajizad E, Wu R, Dennison JB, Do KA, Zhang J, Schmidt CM, Hanash S, Fahrmann JF. León-Letelier RA, et al. Among authors: do ka. Clin Chem. 2024 Jan 4;70(1):102-115. doi: 10.1093/clinchem/hvad186. Clin Chem. 2024. PMID: 38175578 Review.

3

A Novel Sensitivity Maximization at a Given Specificity Method for Binary Classifications.

Ghasemi SM, Gu C, Fahrmann JF, Hanash S, Do KA, Long JP, Irajizad E. Ghasemi SM, et al. Among authors: do ka. Cancer Prev Res (Phila). 2024 Dec 2. doi: 10.1158/1940-6207.CAPR-24-0236. Online ahead of print. Cancer Prev Res (Phila). 2024. PMID: 39618306

4

MicroRNAs are enriched at COVID-19 genomic risk regions, and their blood levels correlate with the COVID-19 prognosis of cancer patients infected by SARS-CoV-2.

Anfossi S, Darbaniyan F, Quinlan J, Calin S, Shimizu M, Chen M, Rausseo P, Winters M, Bogatenkova E, Do KA, Martinez I, Li Z, Antal L, Olariu TR, Wistuba I, Calin GA. Anfossi S, et al. Among authors: do ka. Mol Cancer. 2024 Oct 21;23(1):235. doi: 10.1186/s12943-024-02094-9. Mol Cancer. 2024. PMID: 39434078 Free PMC article.

5

Biomarker trajectory for earlier detection of lung cancer.

Irajizad E, Fahrmann JF, Toumazis I, Vykoukal J, Dennison JB, Shen Y, Do KA, Ostrin EJ, Feng Z, Hanash S. Irajizad E, et al. Among authors: do ka. EBioMedicine. 2024 Oct;108:105377. doi: 10.1016/j.ebiom.2024.105377. Epub 2024 Sep 30. EBioMedicine. 2024. PMID: 39353277 Free PMC article.

6

A metabolite-based liquid biopsy for detection of ovarian cancer.

Fahrmann JF, Ghasemi SM, Han CY, Wu R, Dennison JB, Vykoukal J, Celestino J, Lu K, Lu Z, Drescher C, Do KA, Hanash S, Bast RC, Irajizad E. Fahrmann JF, et al. Among authors: do ka. Biomark Res. 2024 Aug 28;12(1):91. doi: 10.1186/s40364-024-00629-2. Biomark Res. 2024. PMID: 39192316 Free PMC article.

7

survivalContour: visualizing predicted survival via colored contour plots.

Shi Y, Zhang L, Do KA, Jenq RR, Peterson CB. Shi Y, et al. Among authors: do ka. Bioinform Adv. 2024 Jul 25;4(1):vbae105. doi: 10.1093/bioadv/vbae105. eCollection 2024. Bioinform Adv. 2024. PMID: 39086987 Free PMC article.

8

Analysis of Microbiome Data.

Peterson CB, Saha S, Do KA. Peterson CB, et al. Among authors: do ka. Annu Rev Stat Appl. 2024 Apr;11(1):483-504. doi: 10.1146/annurev-statistics-040522-120734. Epub 2023 Oct 13. Annu Rev Stat Appl. 2024. PMID: 38962089

9

Validation of a Blood-Based Protein Biomarker Panel for a Risk Assessment of Lethal Lung Cancer in the Physicians' Health Study.

Song L, Irajizad E, Rundle A, Sesso HD, Gaziano JM, Vykoukal JV, Do KA, Dennison JB, Ostrin EJ, Fahrmann JF, Perera F, Hanash S. Song L, et al. Among authors: do ka. Cancers (Basel). 2024 May 30;16(11):2070. doi: 10.3390/cancers16112070. Cancers (Basel). 2024. PMID: 38893188 Free PMC article.

10

A novel method to guide biomarker combinations to optimize the sensitivity.

Ghasem SM, Fahrmann JF, Hanash S, Do KA, Long JP, Irajizad E. Ghasem SM, et al. Among authors: do ka. bioRxiv [Preprint]. 2024 Apr 15:2024.04.12.589302. doi: 10.1101/2024.04.12.589302. bioRxiv. 2024. PMID: 38659773 Free PMC article. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters